table of content
1 Introduction to Research & Analysis Reports
1.1 Non-invasive Cancer Diagnosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-invasive Cancer Diagnosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-invasive Cancer Diagnosis Overall Market Size
2.1 Global Non-invasive Cancer Diagnosis Market Size: 2022 VS 2030
2.2 Global Non-invasive Cancer Diagnosis Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-invasive Cancer Diagnosis Players in Global Market
3.2 Top Global Non-invasive Cancer Diagnosis Companies Ranked by Revenue
3.3 Global Non-invasive Cancer Diagnosis Revenue by Companies
3.4 Top 3 and Top 5 Non-invasive Cancer Diagnosis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non-invasive Cancer Diagnosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-invasive Cancer Diagnosis Players in Global Market
3.6.1 List of Global Tier 1 Non-invasive Cancer Diagnosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-invasive Cancer Diagnosis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-invasive Cancer Diagnosis Market Size Markets, 2022 & 2030
4.1.2 Clinical Chemistry
4.1.3 Immunochemistry/Immunoassay
4.1.4 Molecular Diagnostics
4.1.5 Others
4.2 By Type - Global Non-invasive Cancer Diagnosis Revenue & Forecasts
4.2.1 By Type - Global Non-invasive Cancer Diagnosis Revenue, 2018-2023
4.2.2 By Type - Global Non-invasive Cancer Diagnosis Revenue, 2024-2030
4.2.3 By Type - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-invasive Cancer Diagnosis Market Size, 2022 & 2030
5.1.2 Blood Cancer
5.1.3 Solid Tumors
5.1.4 Breast Cancer
5.1.5 Lung Cancer
5.1.6 Others
5.2 By Application - Global Non-invasive Cancer Diagnosis Revenue & Forecasts
5.2.1 By Application - Global Non-invasive Cancer Diagnosis Revenue, 2018-2023
5.2.2 By Application - Global Non-invasive Cancer Diagnosis Revenue, 2024-2030
5.2.3 By Application - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Non-invasive Cancer Diagnosis Market Size, 2022 & 2030
6.2 By Region - Global Non-invasive Cancer Diagnosis Revenue & Forecasts
6.2.1 By Region - Global Non-invasive Cancer Diagnosis Revenue, 2018-2023
6.2.2 By Region - Global Non-invasive Cancer Diagnosis Revenue, 2024-2030
6.2.3 By Region - Global Non-invasive Cancer Diagnosis Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Non-invasive Cancer Diagnosis Revenue, 2018-2030
6.3.2 US Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.3.3 Canada Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.3.4 Mexico Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Non-invasive Cancer Diagnosis Revenue, 2018-2030
6.4.2 Germany Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4.3 France Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4.4 U.K. Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4.5 Italy Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4.6 Russia Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4.7 Nordic Countries Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.4.8 Benelux Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Non-invasive Cancer Diagnosis Revenue, 2018-2030
6.5.2 China Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.5.3 Japan Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.5.4 South Korea Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.5.5 Southeast Asia Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.5.6 India Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Non-invasive Cancer Diagnosis Revenue, 2018-2030
6.6.2 Brazil Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.6.3 Argentina Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-invasive Cancer Diagnosis Revenue, 2018-2030
6.7.2 Turkey Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.7.3 Israel Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.7.4 Saudi Arabia Non-invasive Cancer Diagnosis Market Size, 2018-2030
6.7.5 UAE Non-invasive Cancer Diagnosis Market Size, 2018-2030
7 Non-invasive Cancer Diagnosis Companies Profiles
7.1 Gen-Probe Inc.
7.1.1 Gen-Probe Inc. Company Summary
7.1.2 Gen-Probe Inc. Business Overview
7.1.3 Gen-Probe Inc. Non-invasive Cancer Diagnosis Major Product Offerings
7.1.4 Gen-Probe Inc. Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.1.5 Gen-Probe Inc. Key News & Latest Developments
7.2 A&G Pharmaceutical
7.2.1 A&G Pharmaceutical Company Summary
7.2.2 A&G Pharmaceutical Business Overview
7.2.3 A&G Pharmaceutical Non-invasive Cancer Diagnosis Major Product Offerings
7.2.4 A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.2.5 A&G Pharmaceutical Key News & Latest Developments
7.3 Affymetrix Inc.
7.3.1 Affymetrix Inc. Company Summary
7.3.2 Affymetrix Inc. Business Overview
7.3.3 Affymetrix Inc. Non-invasive Cancer Diagnosis Major Product Offerings
7.3.4 Affymetrix Inc. Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.3.5 Affymetrix Inc. Key News & Latest Developments
7.4 Digene Corporation
7.4.1 Digene Corporation Company Summary
7.4.2 Digene Corporation Business Overview
7.4.3 Digene Corporation Non-invasive Cancer Diagnosis Major Product Offerings
7.4.4 Digene Corporation Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.4.5 Digene Corporation Key News & Latest Developments
7.5 Quest Diagnostics Inc.
7.5.1 Quest Diagnostics Inc. Company Summary
7.5.2 Quest Diagnostics Inc. Business Overview
7.5.3 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Major Product Offerings
7.5.4 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.5.5 Quest Diagnostics Inc. Key News & Latest Developments
7.6 BioView Inc.
7.6.1 BioView Inc. Company Summary
7.6.2 BioView Inc. Business Overview
7.6.3 BioView Inc. Non-invasive Cancer Diagnosis Major Product Offerings
7.6.4 BioView Inc. Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.6.5 BioView Inc. Key News & Latest Developments
7.7 LabCorp
7.7.1 LabCorp Company Summary
7.7.2 LabCorp Business Overview
7.7.3 LabCorp Non-invasive Cancer Diagnosis Major Product Offerings
7.7.4 LabCorp Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.7.5 LabCorp Key News & Latest Developments
7.8 AVIVA Biosciences Corporation
7.8.1 AVIVA Biosciences Corporation Company Summary
7.8.2 AVIVA Biosciences Corporation Business Overview
7.8.3 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Major Product Offerings
7.8.4 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.8.5 AVIVA Biosciences Corporation Key News & Latest Developments
7.9 Precision Therapeutics
7.9.1 Precision Therapeutics Company Summary
7.9.2 Precision Therapeutics Business Overview
7.9.3 Precision Therapeutics Non-invasive Cancer Diagnosis Major Product Offerings
7.9.4 Precision Therapeutics Non-invasive Cancer Diagnosis Revenue in Global Market (2018-2023)
7.9.5 Precision Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
